Profiel
Ellen Cavaleri is currently Head-Investor Relations at PTC Therapeutics, Inc. since 2024.
Formerly, worked as Senior VP-Investor Relations & Communications at Lyra Therapeutics, Inc. from 2022 to 2024, and served as Investor Relations Contact at Kadmon Holdings, Inc. Education includes an undergraduate degree from Vanderbilt University and an MBA from New York University.
Actieve functies van Ellen Cavaleri
| Bedrijven | Functie | Begin |
|---|---|---|
| PTC THERAPEUTICS, INC. | Investor Relations Contact | 01-11-2024 |
Eerdere bekende functies van Ellen Cavaleri
| Bedrijven | Functie | Einde |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Investor Relations Contact | 01-06-2024 |
| KADMON HOLDINGS, INC. | Investor Relations Contact | - |
Opleiding van Ellen Cavaleri
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Kadmon Holdings, Inc.
Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
















